Analysis of factors affecting increase in bone mineral density at lumbar spine by bisphosphonate treatment in postmenopausal osteoporosis

Journal of Bone and Mineral Metabolism

Volumn 27, Issue 1, 2009, Pages 76-82

  Kaji, Hiroshi ^a   Hisa, Itoko ^a   Inoue, Yoshifumi ^a   Naito, Junko ^a   Sugimoto, Toshitsugu ^b   Kasuga, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Bisphosphonate; Body composition; Bone mineral density; Glucose; Osteoporosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; DEOXYPYRIDINOLINE; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BONE DENSITY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL;

ABSORPTIOMETRY, PHOTON; AGED; AGED, 80 AND OVER; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 58149202235     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-008-0005-y     Document Type: Article

References (35)

1. UA Liberman SR Weiss J Broll HW Minne H Quan NH Bell J Rodoriguez-Portales RW Downs J Dequeker M Favus E Seeman RR Recker T Capizzi AC Santora A Lombardi RV Shan LJ Hirsch DB Karpf for The Alendronate Phase III Osteoporosis Treatment Study Group 1995 Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis N Engl J Med 333 1437 1443
2. A Cranney G Wells A Willan L Griffith N Zytaruk V Robinson D Black J Adachi B Shea P Tugwell G Guyatt The Osteoporosis Methodology Group The Osteoporosis Research Advisory Group 2002 Meta-analysis of alendronate for the treatment of postmenopausal women Endocr Rev 23 508 516
3. A Cranney P Tugwell J Adachi B Weaver N Zytaruk A Papaioannou V Robinson B Shea G Wells G Guyatt The Osteoporosis Methodology Group The Osteoporosis Research Advisory Group 2002 Meta-analysis of risedronate for the treatment of postmenopausal women Endocr Rev 23 517 523
4. KE Ensrud RC Lipschtz JA Cauley D Seeley MC Nevitt J Scott ES Orwoll HK Genant SR Cummings 1997 Body size and hip fracture risk in older women: a prospective study. Study of Osteoporotic Fractures Research Group Am J Med 103 274 280
5. MC Hochberg DE Thompson DM Black SA Quandt J Cauley P Geusens PD Ross D Baran 2005 Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures J Bone Miner Res 20 971 976
6. SR Cummings DM Black DE Thompson WB Applegate E Barrett-Connor TA Musliner L Parlermo R Prineas 1998 Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the fracture intervention trial JAMA 280 2077 2082
7. JA Kanis IP Barton O Johnell 2005 Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture Osteoporos Int 16 475 482
8. I Shimon V Eshed R Doolman BA Sela A Karasik I Vered 2005 Alendronate for osteoporosis in men with androgen-repleted hypogonadism Osteoporos Int 16 1591 1596
9. SA Jamal DC Bauer KE Ensrud JA Cauley M Hochberg A Ishani SR Cummings 2007 Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial J Bone Miner Res 22 503 508
10. CR Parker PJ Blackwell KJ Fairbairn DJ Hosking 2002 Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study J Clin Endocrinol Metab 87 4482 4489
11. H Nawata S Soen R Takayanagi I Tanaka K Takaoka M Fukunaga T Matsumoto Y Suzuki H Tanaka S Fujiwara T Miki A Sagawa Y Nishizawa Y Seino 2005 Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research J Bone Miner Metab 23 105 109
12. DC Bauer P Garnero MC Hochberg A Santora P Delmas SK Ewing DM Black 2006 Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial J Bone Miner Res 21 292 299
13. H Orimo Y Hayashi H Fukunaga 2001 Diagnostic criteria of primary osteoporosis (2000 revision) Jpn J Bone Miner Res 18 76 82
14. Q Chen H Kaji MF Iu R Nomura H Sowa M Yamauchi T Tsukamoto T Sugimoto K Chihara 2003 Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects J Clin Endocrinol Metab 88 4655 4658
15. P Ruegsegger E Durand MA Dambacher 1991 Localization of regional forearm bone loss from high-resolution computed tomographic images Osteoporos Int 1 76 80
16. RB Mazess HS Barden JP Bisek J Hanson 1990 Dual energy X-ray absorptiometry for total-body and regional bone mineral and soft tissue composition Am J Clin Nutr 51 1106 1112
17. P Vestergaard 2007 Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes: a meta-analysis Osteoporos Int 18 427 444
18. LC Hofbauer CC Brueck SK Singh H Dobnig 2007 Review: osteoporosis in patients with diabetes mellitus J Bone Miner Res 22 1317 1328
19. II de Liefde M va der Klift CE de Laet PL van Daele A Hofman HA Pols 2005 Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study Osteoporos Int 16 1713 1720
20. DE Bonds JC Larson AV Schwartz ES Strotmeyer J Robbins BL Rodriguez KC Johnson KL Margolis 2006 Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study J Clin Endocrinol Metab 91 3404 3410
21. KK Nicodemus AR Folsom 2001 Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women Diabetes Care 24 1192 1197
22. M Inaba M Terada H Koyama O Yoshida E Ishimura T Kawagishi Y Okuno Y Nishizawa S Otani H Morii 1995 Influence of high glucose on 1, 25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells J Bone Miner Res 10 1050 1056
23. R Bouillon M Bex E Van Herck J Laureys L Dooms E Lesaffre E Ravussin 1995 Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus J Clin Endocrinol Metab 80 1194 1202
24. H Lu D Kraut LC Gerstenfeld DT Graves 2003 Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation Endocrinology 144 346 352
25. H Dobnig JC Piswanger-Solkner M Roth B Obermayer-Pietsch A Tiran A Strele E Maier P Maritschnegg C Sieberer A Fahrleitner-Pammer 2006 Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk J Clin Endocrinol Metab 91 3355 3363
26. T Yamaguchi M Kanatani M Yamauchi H Kaji T Sugishita DJ Baylink S Mohan K Chihara T Sugimoto 2006 Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5: their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women Calcif Tissue Int 78 18 24
27. D Nakaoka T Sugimoto H Kaji M Kanzawa S Yano M Yamauchi T Sugishita K Chihara 2001 Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women Osteoporos Int 12 548 554
28. M Kinjo S Setoguchi DH Solomon 2007 Bone mineral density in adults with the metabolic syndrome: analysis in a population-based US sample J Clin Endocrinol Metab 92 4161 4164
29. D von Muhlen S Safii SK Jassal J Svartberg E Barrett-Conner 2007 Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study Osteoporos Int 18 1337 1344
30. MJ Seibel V Naganathan I Barton A Grauer 2004 Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate J Bone Miner Res 19 323 329
31. P Mezquita-Raya M Munoz-Torres JD Luna V Luna F Lopez-Rodriguez E Torres-Vela F Escobar-Jimenez 2001 Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women J Bone Miner Res 16 1408 1415
32. JA Pasco MJ Henry MA Kotowicz KM Sanders E Seeman JR Pasco HG Schneider GC Nicholson 2004 Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong osteoporosis study J Bone Miner Res 19 752 758
33. JC Souberbielle C Cormier C Kindermans P Gao T Cantor F Forette EE Baulieu 2001 Vitamin D status and redefining serum parathyroid hormone reference range in the elderly J Clin Endocrinol Metab 86 3086 3090
34. NB Watts P Gausens IP Barton D Felsenberg 2005 Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD J Bone Miner Res 20 2097 2104
35. MC Hochberg S Greenspan RD Wasnich P Miller DE Thompson PD Ross 2002 Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents J Clin Endocrinol Metab 87 1586 1592